EQUINOX NEPREMICNINE d.d. Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Rental Revenue	8.65	7.63	7.15	6.51	5.98
Other Revenue	1.06	1.04	0.63	0.84	0.73
Total Revenue	9.71	8.67	7.79	7.34	6.71
Revenue Growth (YoY	23.51%	11.36%	6.03%	9.38%	-
Property Expenses	2.15	2.1	1.62	2.42	2.08
Depreciation & Amortization	3.9	3.93	3.76	3.41	3.43
Other Operating Expenses	2.46	2.33	2.04	0.11	0.76
Total Operating Expenses	8.52	8.36	7.42	5.94	6.27
Operating Income	1.2	0.31	0.37	1.4	0.45
Interest Expense	-0.48	-0.51	-0.64	-0.85	-0.33
Interest & Investment Income	1.13	1.58	1.24	0.3	0.19
Other Non-Operating Income	0	0	0	0	0.07
EBT Excluding Unusual Items	1.84	1.38	0.97	0.85	0.38
Asset Writedown	0	0	-	-	-
Pretax Income	1.84	1.38	0.97	0.85	0.38
Income Tax Expense	0.54	0.31	0.1	0.14	-0.16
Net Income	1.3	1.07	0.87	0.71	0.54
Net Income to Common	1.3	1.07	0.87	0.71	0.54
Net Income Growth	-5.17%	23.06%	22.07%	31.87%	-
Basic Shares Outstanding	2	2	2	2	-
Diluted Shares Outstanding	2	2	2	2	-
Shares Change (YoY)	-1.56%	-1.55%	1.73%	-	-
EPS (Basic)	0.73	0.60	0.48	0.40	-
EPS (Diluted)	0.73	0.60	0.48	0.40	-
EPS Growth	-3.66%	25.00%	20.00%	-	-
Dividend Per Share	1.830	1.830	1.690	1.430	-
Dividend Growth	8.28%	8.28%	18.18%	-	-
Operating Margin	12.31%	3.61%	4.72%	19.11%	6.68%
Profit Margin	13.36%	12.34%	11.16%	9.70%	8.04%
EBITDA	5.13	4.25	4.13	4.81	3.88
EBITDA Margin	52.80%	48.96%	53.05%	65.54%	57.83%
D&A For Ebitda	3.93	3.93	3.76	3.41	3.43
EBIT	1.2	0.31	0.37	1.4	0.45
EBIT Margin	12.31%	3.61%	4.72%	19.11%	6.68%
Effective Tax Rate	29.51%	22.29%	10.49%	16.20%	-
Revenue as Reported	9.71	8.67	7.79	7.34	-

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.